P-ISSN 2587-2400 | E-ISSN 2587-196X

Ejmo Kapak

EJMO Volume : 5 Issue : 2 Year : 2021

COVID-19 in EJMO 5/2EJMO Current Issue EJMO Archive EJMO & Congress of Oncology and immunotherapy association Most Cited Articles Ahead of Print Most Accessed Articles

Copyright Transfer Form

ICMJE COI Form

EJMO Sponsors

Arven
Amgen
Astellas
Bristol-Myers Squibb
Johnson Johnson
Merck
Pfizer
Novartis
Omnigen
Mustafa Nevzat
Roche
TEVA
Trpharm

The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2

Copyright � 2021 Eurasian Journal of Medicine and Oncology, EJMO

EJMO & EJMO